We have set up a clear vision for Nordmark's future. This definition allows us to invest specifically in the skills and technology needed in our focus areas. Dr Jörn Tonne, CEO and Managing Director
We have set up a clear vision for Nordmark's future. This definition allows us to invest specifically in the skills and technology needed in our focus areas.
Dr Jörn Tonne, CEO and Managing Director
Quality products, service material and high delivery capacity: our mix for ideal patient care. Volker Kahrmann, Head of Marketing
Quality products, service material and high delivery capacity: our mix for ideal patient care.
Volker Kahrmann, Head of Marketing
Innovation plays a prominent role for us. On the one hand, in the further development and optimisation of our existing business. On the other hand, we are developing into new fields, such as hormone replacement therapy and the isolation and proliferation of stem cells. Dr Jörn Tonne, CEO and Managing Director
Innovation plays a prominent role for us. On the one hand, in the further development and optimisation of our existing business. On the other hand, we are developing into new fields, such as hormone replacement therapy and the isolation and proliferation of stem cells.
07/03/2024
Read more
03/01/2024
02/19/2024
08/11/2023
Norbitec biotech facility in Uetersen, Germany, a company controlled by STADA, passes inspection by the US Food and Drug Administration (FDA).
04/11/2022
The German biotechnology industry will meet again on 4th and 5th May 2022 - for the second time in Hamburg. Nordmark Biotech will again be represented…
03/24/2021
One of the most important construction projects on Nordmark's site is called 'BIBITEC'. Currently, an area of the existing biotechnology centre is…